Key Points
- Insider purchase: Liam Condon bought 10 shares on Feb 11 at GBX 2,342 (total £234.20), his third small buy in three months following purchases on Jan 13 and Dec 10, indicating modest insider accumulation.
- Analyst view and stock position: The stock has a consensus rating of "Moderate Buy" with a target of GBX 2,268, yet opened at GBX 2,345 (near its 1‑year high of GBX 2,434) and carries a negative P/E (‑35.58) with a market cap of about £3.93bn.
Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon purchased 10 shares of the company's stock in a transaction that occurred on Wednesday, February 11th. The stock was bought at an average price of GBX 2,342 per share, with a total value of £234.20.
Liam Condon also recently made the following trade(s):
- On Tuesday, January 13th, Liam Condon acquired 10 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,321 per share, for a total transaction of £232.10.
- On Wednesday, December 10th, Liam Condon acquired 14 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 2,013 per share, with a total value of £281.82.
Johnson Matthey Price Performance
JMAT opened at GBX 2,345 on Friday. The company has a market capitalization of £3.93 billion, a P/E ratio of -35.58, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a 50-day moving average of GBX 2,242.69 and a 200-day moving average of GBX 2,070.92. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a 1-year low of GBX 1,131 and a 1-year high of GBX 2,434.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported GBX 51.20 EPS for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Equities analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Wall Street Analyst Weigh In
JMAT has been the topic of several research reports. Citigroup upped their price target on Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the company a "neutral" rating in a research report on Tuesday, October 21st. Panmure Gordon reissued a "buy" rating and set a GBX 2,370 target price on shares of Johnson Matthey in a report on Monday, November 24th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the stock a "buy" rating in a research report on Wednesday, January 21st. Finally, Berenberg Bank lowered their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,050 and set a "hold" rating for the company in a research report on Tuesday, November 25th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of GBX 2,268.
Read Our Latest Stock Analysis on Johnson Matthey
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
